- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02440282
Comparison of Anesthetic Modalities on Hemodynamic Stability and Postoperative Pain in Diabetic Foot Patients Undergoing Minor Lower Extremity Amputation
July 1, 2015 updated by: Yonsei University
Diabetic foot ulcer is the most common cause of non traumatic lower extremity amputations (LEA) associated with diabetes.
Traditionally general and spinal anesthesia were the preferred modality of anesthesia.
The use of sciatic nerve block has recently gained popularity, however, without the supporting evidence of any benefits.
This study was to evaluate the comparison of anesthesia modalities for hemodynamic stability and postoperative pain in diabetic foot patients undergoing minor LEA.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
86
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 84 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
consecutive 86 diabetic foot patients who underwent minor LEA
Description
Inclusion Criteria:
- diabetic foot patients who underwent minor LEA
Exclusion Criteria:
- emergency cases
- patients who underwent major upper or lower extremity amputations
- patients who received general anesthesia following fail regional or spinal anesthesia
- patients who underwent LEA within 1year, and patients who underwent other concomitant surgeries
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Group A
patients undergo general anesthesia
|
|
Group B
spinal anesthesia
|
|
Group C
ultrasound-guided sciatic nerve block
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean blood pressure
Time Frame: every ten minutes from preinduction to 30minutes after sugery
|
every ten minutes from preinduction to 30minutes after sugery
|
|
Mean blood pressure
Time Frame: from arrival at recovery room until 20miutes after surgery at recovery room
|
from arrival at recovery room until 20miutes after surgery at recovery room
|
|
Heart rate
Time Frame: every ten minutes from preinduction to 30minutes after sugery
|
every ten minutes from preinduction to 30minutes after sugery
|
|
Heart rate
Time Frame: from arrival at recovery room until 20miutes after surgery at recovery room
|
from arrival at recovery room until 20miutes after surgery at recovery room
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
May 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
April 24, 2015
First Submitted That Met QC Criteria
May 6, 2015
First Posted (Estimate)
May 12, 2015
Study Record Updates
Last Update Posted (Estimate)
July 2, 2015
Last Update Submitted That Met QC Criteria
July 1, 2015
Last Verified
July 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4-2014-1022
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Foot Ulcer
-
DEBx Medical B.V.Not yet recruitingDiabetic Foot Wounds | Diabetic Foot Ulcer (DFU) | Diabetic Foot Ulcer Treatment
-
StimLabsNot yet recruitingDiabetic Foot | Foot Ulcer | Ulcer Foot | Diabetic Foot Ulcer (DFU)
-
Applied Biologics, LLCSerena GroupRecruitingUlcer | Diabetic Foot Ulcer | Diabetic Foot Ulcers (DFU) | Foot Ulcer ChronicUnited States
-
Applied Biologics, LLCSerenaGroup, Inc.RecruitingDiabetic Foot | Foot Ulcer | Diabetic Foot Ulcer | Ulcer Foot | Foot Ulcer Due to Type 1 Diabetes Mellitus | Foot Ulcer Due to Type 2 Diabetes Mellitus | DFUUnited States
-
Başakşehir Çam & Sakura City HospitalRecruitingDiabetic Foot Infection | Diabetic Amputation Foot Wound | Diabetic Foot DiseaseTurkey (Türkiye)
-
PolarityTETemporarily not availableNeuropathic Diabetic Ulcer - Foot | Diabetic Foot Disease | DFU
-
Cairo UniversityNot yet recruitingDiabetic Foot UlcerEgypt
-
Omeza, LLCSygNola, LLCRecruitingDiabetic Foot UlcerUnited States
-
Universidad Autonoma de Nuevo LeonCompleted
-
Libyan Center for Biotechnology ResearchNot yet recruiting